Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus
Beseitigung von Barrieren für das Management von Erwachsenen mit Typ-2-Diabetes unter Insulintherapie mittels kontinuierlicher Glukosemessung in der hausärztlichen Versorgung in Großbritannien: Expertenkonsens
Diabetic Medicine · 2025-03 · 42 (3)
DOI: 10.1111/dme.15500 ↗Auf einen Blick
Ein Expertenkonsens beschreibt Bedürfnisse, Barrieren und Chancen für den Einsatz von CGM bei Erwachsenen mit Typ-2-Diabetes unter nicht-intensiver Insulintherapie in der britischen Primärversorgung.
Fragestellung
Welche unmet needs, Barrieren und Umsetzungsfragen bestehen in der hausärztlichen Versorgung von Erwachsenen mit Typ-2-Diabetes unter Insulintherapie beim Einsatz von CGM?
Methode
Expertenkonsens mit 2 Primärversorgungs-Konsensuspanels und 2 Delphi-Befragungen unter Mitgliedern des Primary Care Diabetes Technology Network UK.
Ergebnisse
Die Panels identifizierten Trainings- und Bildungsbedarf sowie Barrieren wie fehlendes Vertrauen in Leitlinien, mangelnde Erfahrung, Arbeitsabläufe und Widerstand gegen Veränderungen. 94,3 % (n = 33) hielten CGM als Standardversorgung für erreichbar.
Schlussfolgerung der Autor:innen
Die Anpassung der Versorgung von Menschen mit Typ-2-Diabetes unter Insulintherapie belastet aktuelle Abläufe und Kompetenzen in Primärversorgungsteams erheblich; die Mehrheit der Expert:innen erwartet CGM als künftigen Standard.
Kernaussagen
- Trainings- und Bildungsbedarf in der Primärversorgung wurde identifiziert
- Barrieren: Leitlinienvertrauen, Erfahrung, Abläufe und Widerstand gegen Wandel
- 94,3 % (n = 33) sahen CGM als Standardversorgung als erreichbar an
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 15.12.2024. Verfasst von Samuel Seidu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, National Institute for Health Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, U…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Primary Health Care, Insulin, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott Diabetes Care.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
This expert consensus reviews the reality of primary care clinical management of people with type 2 diabetes (T2D) on non‐intensive insulin therapy, with an emphasis on the use of continuous glucose monitoring (CGM) technology for effective care in this participant group. Here, we identify key unmet needs for skills and systems development within this frontline healthcare setting, along with major challenges and opportunities associated with managing these changes effectively.
Methods
The authors participated in two primary care consensus panels held on 28 November 2023 and on 21 May 2024. The focus for these expert panels was to understand the unmet needs within primary care to manage adults with T2D treated with non‐intensive insulin therapy and incorporating the use of CGM systems. A Delphi Survey was undertaken among a wider group of Primary Care Diabetes Technology Network members in the United Kingdom, to understand prevalent attitudes to management of adults with T2D on insulin and using CGM in primary care. Based on these activities, a series of consensus statements were tested in a second Delphi Survey.
Results
The activities described, involving primary care healthcare professionals (HCPs) with expertise in diabetes management, identified a series of training and educational needs within UK general practice that are central to skills development for the care of adults with T2D on insulin therapy and the application of CGM technology. Potential barriers to effective primary care management of people with T2D using CGM devices were identified. Areas of concern included confidence in national and local guidelines for the management of T2D using CGM systems, lack of experience on the part both of HCPs and people with T2D, clinical workflows and systems, as well as inbuilt resistance to change among primary care teams. However, the expert group were clear that the goal of providing care for people with T2D on non‐intensive insulin therapy using CGM technology as standard of care could be met (94.3%, n = 33). This will deliver clinical benefits for people with T2D, and improvements to clinical workflows in primary care. Cost‐savings to the health service were also identified as an outcome.
Conclusions
The need to adapt to the management of people with T2D on insulin therapy puts significant pressure on current workflows and skills for primary care teams. Steps in overcoming these immediate pressures, to ensure effective clinical management of people with T2D, are discussed, along with a series of consensus statements that identify the key areas of change to manage. Ultimately, the great majority of expert primary care HCPs were confident or very confident that using CGM technology will become the standard of care for people with T2D treated with insulin in primary care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Centre, National Institute for Health Research, Applied Research Collaboration East Midlands, University of Leicester, Leicester, UK.
- Solent NHS Trust, Portsmouth, UK.
- Old School Surgery, Carrickfergus, UK.
- Swansea, London, UK.
- College Lane Surgery, Ackworth, UK.
- Somerset Partnership NHSFT, London, UK.
ORCID-Profile: Patrick Holmes
Förderung
- Abbott Diabetes Care
Zitieren
APA
Seidu, S., Avery, L., Bell, H., Brown, P., Diggle, J., Down, S., Dua, R., Holmes, P., Mohan, R., Milne, N., Min, T., Ridgeway, J., Tahir, W., & Tanna, S. (2025). Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus. Diabetic Medicine, 42(3). https://doi.org/10.1111/dme.15500
Vancouver
Seidu S, Avery L, Bell H, Brown P, Diggle J, Down S, et al. Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus. Diabetic Medicine. 2025;42(3). doi:10.1111/dme.15500
BibTeX
@article{Seidu2025,
author = {Seidu, Samuel and Avery, Lorraine and Bell, Heather and Brown, Pam and Diggle, Jane and Down, Su and Dua, Ritesh and Holmes, Patrick and Mohan, Rahul and Milne, Nicola and Min, Thinzar and Ridgeway, James and Tahir, Waqas and Tanna, Sanjay},
title = {Removing barriers to management of adults with type 2 diabetes on insulin using continuous glucose monitoring in UK primary care practice: An expert consensus},
journal = {Diabetic Medicine},
year = {2025},
volume = {42},
number = {3},
doi = {10.1111/dme.15500}
}
EUVIMED